Perfusion impairment in patients with normal-appearing coronary arteries: Identification with contrast-enhanced MR imaging

Radiology

Volumn 238, Issue 2, 2006, Pages 464-472

  De Ávila, Luíz Francisco Rodrigues ^a   Fernandas, Juliano Lara ^a   Rochitte, Carlos Eduardo ^a   Cerri, Giovanni G ^a   Parga, José Filho ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; GADOLINIUM PENTETATE; NITRATE; STATINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FEMALE; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA TO REST RATIO; IMAGE ENHANCEMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL INTENSITY; SIGNAL PROCESSING; STATISTICAL MODEL;

CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 31144434069     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2382041697     Document Type: Article

References (46)

1. American Heart Association. 1999 heart and stroke statistical update. Dallas, Tex: American Heart Association, 1999.
2. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stahle angina: summary article-a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168.
3. Marcus ML, Harrison DG, White CW. McPherson DD, Wilson RF, Kerber RE. Assessing the physiologic significance of coronary obstructions in patients: importance of diffuse undetected atherosclerosis. Prog Cardiovasc Dis 1988;31:39-56.
4. Litchfield RL. Noninvasive tests for cardiac risk stratification: which ones are most prognostic? Postgrad Med 2004;115:30-36.
5. Chiu CVV, So NM, Lam WW, Chan KY, Sanderson JE. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study. Radiology 2003;226:717-722.
6. Viswamitra S, Higgins CB, Meacham DF, Mehta JL. Magnetic resonance imaging in myocardial ischemia. Curr Opin Cardiol 2004;19:510-S16.
7. Atkinson DJ, Burstein D. Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology 1990;174:757-762.
8. Jerosch-Herold M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Card Imaging 1997;13:205-218.
9. Ishida N, Sakuma H, Motoyasu M, et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology 2003;229:209-216.
10. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004;110:835-842.
11. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004;109:2080-2085.
12. Panting JE, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
13. Imaging guidelines for nuclear cardiology procedures. II. American Society of Nuclear Cardiology. J Nucl Cardiol 1999;6:G47-G84.
14. Hendel RC, Wackers FJ, Berman DS, et al. American Society of Nuclear Cardiology consensus statement: reporting of radionuclide myocardial perfusion imaging studies. J Nucl Cardiol 2003;10:705-708.
15. L'Abbate A. Sambuceti G, Neglia D. Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application. J Nucl Cardiol 2002;9:328-337.
16. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thrornb Vasc Biol 2003;23:168-175.
17. De Bruyne B, Hersbach F, Pijls NH, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation 2001;104:2401-2406.
18. Could KL. Nonirivasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-278.
19. Johnston DL, Daley JR, Hodge DO, Hopfen-spirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc 1995;70:331-336.
20. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15:459-474.
21. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31:534-540.
22. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-817.
23. Yoshinaga K, Katoh C, Noriyasu K, et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol 2003;10:275-283.
24. Sdringola S, Patel D, Gould KL. High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease. Circulation 2001;103:496-501.
25. Heusch G. Hibernating myocardium. Physiol Rev 1998;78:1055-1085.
26. Rahimtoola SH. Hibernating myocardium bas reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996;94:3055-3061.
27. Walsh EG, Doyle M, Lawson MA, Blackwell GG, Pohost GM. Multislice first-pass myocardial perfusion imaging on a conventional clinical scanner. Magn Reson Med 1995;34:39-47.
28. de Roos A, Niezen RA, Lamb HJ, Dendale P, Reiber JH, van der Wall EE. MR of the heart under pharmacologic stress. Cardiol Clin 1998;16:247-265.
29. van Rugge FP, van der Wall EE, Bruschke AV. New developments in pharmacologic stress imaging. Am Heart J 1992;124:468-485.
30. Sensky PR, Jivan A, Hudson NM, et al. Coronary artery disease: combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function. Radiology 2000;215:608-614.
31. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-384.
32. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235.
33. Hundley WG, Lange RA, Clarke GD, et al. Assessment of coronary arterial flow and flow reserve in humans with magnetic resonance imaging. Circulation 1996;93:1502-1508.
34. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383.
35. Cullen JH, Horsfield MA, Reek CR, Cherryman GR, Barnett DB, Samani NJ. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33:1386-1394.
36. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-1788.
37. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process. Circulation 2002;106:760-762.
38. Sutton-Tyrrell K, Kuller LH, Matthews KA, et al. Subclinical atherosclerosis in multiple vascular beds: an index of atherosclerotic burden evaluated in postmenopausal women. Atherosclerosis 2002;160:407-416.
39. Fowkes FG, Price JF, Leng GC. Targeting subclinical atherosclerosis. BMJ 1998;316:1764.
40. O'Keefe JH Jr, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dL: lower is better and physiologically normal. J Am Coll Cardiol 2004;43:2142-2146.
41. Khaleeli E, Peters SR, Bobrowsky K, Oucliz RJ, Ko JY, Budoff MJ. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: implications for management. Am Heart J 2001;141:637-644.
42. Olin JW, Kaufman JA, Bluemke DA, et al. Atherosclerotic vascular disease conference: Writing Group IV-imaging. Circulation 2004;109:2626-2633.
43. Shaw LJ, Redberg RF. From clinical trials to public health policy: the path from imaging to screening. Am J Cardiol 2001;88:62E-65E.
44. Koerselman J, van der Graaf Y, de Jaegere PP, Grobbee DE. Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003;107:2507-2511.
45. Sensky PR, Samani NJ. Reek C, Cherryman GR. Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach. Int J Cardiovasc Imaging 2002;18:373-383.
46. Thiele H, Plein S, Ridgway JP, et al. Effects of missing dynamic images on myocardial perfusion reserve index calculation: comparison between an every heartbeat and an alternate heartbeat acquisition. J Cardiovasc Magri Reson 2003;5:343-352.